13 Million Freeze-Dried Monkeypox – Smallpox Vaccines Ordered — Precision Vaccinations

Denmark-based Bavarian Nordic A/S announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA) exercised the first options under an existing contract to supply a freeze-dried version of the JYNNEOS® smallpox vaccine. The first doses of this vaccine version will be manufactured and invoiced in 2023 and 2024.

Source: 13 Million Freeze-Dried Monkeypox – Smallpox Vaccines Ordered — Precision Vaccinations

2 thoughts on “13 Million Freeze-Dried Monkeypox – Smallpox Vaccines Ordered — Precision Vaccinations

  • May 18, 2022 at 7:23 pm
    Permalink

    *Monkeypox typically presents clinically with fever, rash and swollen lymph nodes.

    Monkeypox virus is mostly transmitted to people from wild animals such as rodents and primates, but human-to-human transmission also occurs.

    *Monkeypox virus is transmitted from one person to another by contact with lesions, body fluids, respiratory droplets and contaminated materials such as bedding.

    *Typically, up to a tenth of persons ill with monkeypox may die, with most deaths occurring in younger age groups.

    *The clinical presentation of monkeypox resembles that of smallpox, a related orthopoxvirus infection which was declared eradicated worldwide in 1980.

    *Vaccinia vaccine used during the smallpox eradication programme was also protective against monkeypox. A new third generation vaccinia vaccine has now been approved for prevention of smallpox and monkeypox. Antiviral agents are also being developed.

    https://www.who.int/news-room/fact-sheets/detail/monkeypox

Comments are closed.

Translate »
Exit mobile version